Dhoot'S Chemo Plast Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 09-12-2024
- Paid Up Capital ₹ 5.00 M
as on 09-12-2024
- Company Age 54 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 32.80 Cr
as on 09-12-2024
- Satisfied Charges ₹ 3.93 Cr
as on 09-12-2024
- Revenue -61.50%
(FY 2022)
- Profit -5.85%
(FY 2022)
- Ebitda -636.59%
(FY 2022)
- Net Worth 13.88%
(FY 2022)
- Total Assets -12.92%
(FY 2022)
About Dhoot'S Chemo Plast
The Corporate was formerly known as Dhoot Chemo Plast Private Limited. The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹32.80 Cr. The company has closed loans amounting to ₹3.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Archana Dhoot, Viveek Sable, and Srinidhi Dhoot serve as directors at the Company.
- CIN/LLPIN
U25209MH1970PTC014761
- Company No.
014761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 1970
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationAurangabad, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dhoot'S Chemo Plast?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Dhoot  | Director | 25-Jun-2022 | Current |
| Viveek Sable | Director | 15-Jun-2021 | Current |
| Srinidhi Dhoot | Director | 12-Aug-2023 | Current |
Financial Performance of Dhoot'S Chemo Plast.
Dhoot'S Chemo Plast Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 61.5% decrease. The company also saw a slight decrease in profitability, with a 5.85% decrease in profit. The company's net worth Soared by an impressive increase of 13.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhoot'S Chemo Plast?
In 2021, Dhoot'S Chemo Plast had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Mar 2022 | ₹15.04 Cr | Open |
Others Creation Date: 09 Dec 2021 | ₹16.50 Cr | Open |
Industrial Development Bank Of India Creation Date: 31 Mar 1995 | ₹4.60 M | Open |
How Many Employees Work at Dhoot'S Chemo Plast?
Dhoot'S Chemo Plast has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhoot'S Chemo Plast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhoot'S Chemo Plast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
